# A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol

> **NCT03562949** · PHASE3 · TERMINATED · sponsor: **Amneal Ireland Limited** · enrollment: 761 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Test Product
- **DRUG:** Reference Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03562949
- **Lead sponsor:** Amneal Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-06
- **Primary completion:** 2019-08-02
- **Final completion:** 2019-08-02
- **Target enrollment:** 761 (ACTUAL)
- **Why stopped:** Insufficient investigational product
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562949, "A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03562949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*